• Cefazedone (Refosporen): From MIC to Translation

  2026-09-01

  A translational framework for connecting Cefazedone mechanism, assay design, bioanalytical validation, and PK/PD interpretation across antibacterial research workflows.

• Diphenyleneiodonium Chloride: Redox & cAMP

  2026-09-01

  Diphenyleneiodonium chloride, or DPI, is a broad flavoprotein inhibitor and GPR3 agonist used to study redox enzyme function and cAMP signaling modulation. Its activity across NOX, nitric oxide synthase, cytochrome P450 reductase, and GPR3 systems makes it useful but unsuitable as a pathway-specific inhibitor without orthogonal controls.

• X-Gal Workflows for Cloning and Reporter Assays

  2026-08-31

  Build cleaner blue-white colony screening workflows with X-Gal, from stock preparation and plate setup to clone validation and reporter optimization. The article also translates recent iRhom2 olfaction findings into practical assay-design choices without overstating what X-Gal can measure.

• Mechanical Stress, Cytoskeleton, and Autophagy

  2026-08-31

  The reference study shows that autophagy triggered by cellular compression depends strongly on the cytoskeleton, with microfilaments acting as the principal structural component and microtubules providing auxiliary support. By combining cytoskeletal polymerization perturbations, fluorescence imaging, and western blotting, the work moves beyond correlation to define a structural requirement for mechanical stress-induced autophagy.

• Hyaluronic Acid Sodium Salt for siRNA Workflows

  2026-08-30

  Hyaluronic acid sodium salt connects extracellular-matrix modeling with nanoparticle-enabled immune-cell research. This guide translates the HA-coated siRNA strategy used in Pseudomonas aeruginosa lung-injury models into practical dispersion, coating, assay, and troubleshooting workflows.

• Hypothermic Albumin Perfusion in Ischemic Stroke

  2026-08-29

  A 2026 study reports that intra-arterial selective cooling human serum albumin infusion provides stronger neuroprotection than selective cooling saline or either component alone in a rat middle cerebral artery occlusion model. The intervention reduced neuroinflammation, improved longer-term neurological recovery, and was associated with less blood-brain barrier disruption through suppression of the ROCK1/MLC–F-actin axis.

• Cytoskeleton-Dependent Autophagy Under Compression

  2026-08-28

  The reference study provides direct cellular evidence that compression-induced autophagy depends primarily on microfilaments, while microtubules make a supporting contribution. Its combined use of mechanical loading, cytoskeletal polymerization perturbation, fluorescence imaging, and western blotting offers a useful framework for studying mechanotransduction and autophagic responses.

• FOXO3–YAP Metabolic Targeting in HCC

  2026-08-28

  The reference study identifies FOXO3 as a tumor-suppressive regulator that simultaneously restrains glycolysis and glutaminolysis in hepatocellular carcinoma through transcriptional repression of YAP. Its combination of mechanistic promoter analysis, pharmacological activation, animal studies, and patient-derived organoids supports the FOXO3/YAP axis as a candidate metabolic intervention point, while leaving important questions about model specificity and clinical translation.

• Risedronate Sodium: From FPPS to Better Assays

  2026-08-27

  Risedronate Sodium is a mechanistically distinctive FPP synthase inhibitor for bone metabolism research and emerging pulmonary models. This article explains how to design interpretable osteoclast, viability, formulation, and translational assays without confusing bisphosphonate biology with NSAID-based cancer findings.

• Anlotinib hydrochloride: Angiogenesis Assay Guide

  2026-08-27

  Build more informative angiogenesis experiments with Anlotinib hydrochloride, a multi-target tyrosine kinase inhibitor that links VEGFR2, PDGFRβ, FGFR1, and ERK pathway biology to functional endothelial readouts. This guide translates the reference study into practical workflows, controls, dose design, and troubleshooting strategies for cancer research.

• Auranofin and Metabolic Redox Stress in HCC

  2026-08-26

  Auranofin is a thioredoxin reductase inhibitor that offers a mechanistically distinct way to study redox vulnerability in hepatocellular carcinoma. This article connects TrxR inhibition with the FOXO3/YAP metabolic framework while separating established evidence from testable assay hypotheses.

• FITC Goat Anti-Rabbit IgG (H+L): Assay Design

  2026-08-26

  Learn how the FITC Goat Anti-Rabbit IgG (H+L) Antibody can support orthogonal validation of proteomic biomarkers such as HMGB1. This guide connects secondary-antibody chemistry with assay controls, workflow design, and translational interpretation.

• RISOTTO Trial: Risedronate in RA-Related GIO

  2026-08-25

  The RISOTTO study evaluated sodium risedronate for glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis using a multicentre, randomized, double-blind, placebo-controlled design. Risedronate produced a clear six-month improvement in lumbar spine bone mineral density and was well tolerated, while the lack of significant hip effects and short follow-up define the appropriate limits of interpretation.

• Antipyrine as a Translational CNS Benchmark

  2026-08-25

  Antipyrine can serve as a practical reference compound for connecting analgesic and antipyretic pharmacology with BBB permeability, pharmacokinetic studies, and drug metabolism research.

• SB 431542 Workflows for TGF-β Assays

  2026-08-24

  SB 431542 is a selective ALK5 inhibitor for dissecting TGF-β-dependent Smad2 signaling, trophoblast–immune interactions, and cancer-cell phenotypes. This workflow combines primary HLA-G+ extravillous trophoblast models with practical dosing, controls, and troubleshooting guidance.

8545 records 1/570 page Next 12345 下5页 Last page